CasLoc logo
All Cases PTAB Litigations UPC Oppositions

IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC.

2:15-cv-06934

Overview

Case Number 2:15-cv-06934
Filing Date 2015-09-17
Status Terminated
Termination Date 2018-06-25
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

ACTAVIS PHARMA INC. Operating Company

Represented By

4 Attorneys Listed

READE WILLIAM SELIGMANN

Alston & Bird LLP

Tel: +1 (212) 210-9400

90 Park Avenue, New York, NY 10016

HECTOR DANIEL RUIZ

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1100

ONE RIVERFRONT PLAZA, 1037 RAYMOND BLVD.

ELEONORE OFOSU-ANTWI

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1100

ONE RIVERFRONT PLAZA, 1037 RAYMOND BLVD., 6TH FLOOR

LIZA M. WALSH

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1100

ONE RIVERFRONT PLAZA, 1037 RAYMOND BLVD.

ACTAVIS LABORATORIES FL, INC. Operating Company

Represented By

4 Attorneys Listed

READE WILLIAM SELIGMANN

Alston & Bird LLP

Tel: +1 (212) 210-9400

90 Park Avenue, New York, NY 10016

HECTOR DANIEL RUIZ

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1100

ONE RIVERFRONT PLAZA, 1037 RAYMOND BLVD.

ELEONORE OFOSU-ANTWI

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1100

ONE RIVERFRONT PLAZA, 1037 RAYMOND BLVD., 6TH FLOOR

LIZA M. WALSH

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1100

ONE RIVERFRONT PLAZA, 1037 RAYMOND BLVD.

Plaintiff

IMPAX LABORATORIES, INC. Operating Company

Represented By

2 Attorneys Listed

MICHAEL E. PATUNAS

PATUNAS LAW LLC

24 COMMERCE STREET, SUITE 606

MAYRA VELEZ TARANTINO

PATUNAS TARANTINO LLC

PATUNAS TARANTINO LLC, 24 COMMERCE STREET

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 13 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (13): πŸ‡¨πŸ‡¦ Canada πŸ‡ͺπŸ‡Ί Europe πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7094427
Combination immediate release controlled release levodopa/carbidopa dosage forms
Filed: 2002-09-12
Issued: 2006-08-22
Expired (Term Ended)
Expires: 2022-09-12
US8377474
Controlled release formulations of levodopa and uses thereof
Filed: 2008-12-26
Issued: 2013-02-19
Active (2.1 yrs remaining)
Expires: 2028-12-26

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

48

Dispositive

24

Granted

10

Denied

0

Pending / Review

19

Motions by Category

Procedural / Extension Motion 9 Motion to Stay 8 Motion to Stay Pending IPR / Reexam 1 Claim Construction / Markman Filing 7 Motion for Summary Judgment (Rule 56) 21 Motion for Summary Judgment (Infringement) 2

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Infringement) Granted in Part
AMENDED OPINION/ORDER that Actavis motion for summary judgment of noninfringement (Docket Entry No. 142), pursuant to Federal Rule of Civil Procedure 56), is GR...
Entry #192 • 2018-04-18 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
Letter from Liza M. Walsh to Judge Stanley R. Chesler, U.S.D.J. re 184 Order, 180 Order on Motion for Summary Judgment,. (WALSH, LIZA) (Entered: 03/28/2018)
Entry #185 • 2018-03-28 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
Letter from Liza M. Walsh to Judge Cathy L. Waldor, U.S.M.J., Seeking Extension of Deadline to File Motion to Seal Opinion re 180 Order on Motion for Summary Ju...
Entry #183 • 2018-03-22 Document →
Motion for Summary Judgment (Infringement) Granted
OPINION/ORDER granting in part and denying in part 142 Motion for Summary Judgment; that Actavis is barred from using its two-range calculation theory as adefen...
Entry #180 • 2018-03-08 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
Minute Entry for proceedings held before Judge Stanley R. Chesler: Motion Hearing held on 2/27/2018 re 142 MOTION for Summary Judgment filed by ACTAVIS PHARMA I...
Entry #179 • 2018-02-27 Document →
Motion for Summary Judgment (Rule 56) Pending
Set/Reset Deadlines as to 142 MOTION for Summary Judgment . Motion set for 2/27/2018 03:00 PM before Judge Stanley R. Chesler. ORDERED ALL PARTIES TO APPEAR REA...
Entry #β€” • 2018-02-20

Docket Entries

(349 total)
Pleading / Complaint

COMPLAINT against ACTAVIS LABORATORIES FL, INC., ACTAVIS PHARMA INC. ( Filing and Admin fee $ 400 receipt number 0312-6646274), filed by IMPAX LABORATORIES, INC.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(seb) (Entered: 09/18/2015)

Entry #1 • 2015-09-17
1
Pleading / Complaint

AO120 Patent/Trademark Form filed. (Attachments: # 1 Complaint, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6) (seb) (Entered: 09/18/2015)

Entry #2 • 2015-09-17
1

Corporate Disclosure Statement by IMPAX LABORATORIES, INC. identifying NONE as Corporate Parent.. (seb) (Entered: 09/18/2015)

Entry #3 • 2015-09-17
1

SUMMONS ISSUED as to ACTAVIS LABORATORIES FL, INC., ACTAVIS PHARMA INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *STEPHEN BOND* (seb) (Entered: 09/18/2015)

Entry #4 • 2015-09-18
1

Minute Entry for proceedings held before Judge Katharine S. Hayden: Pursuant to Local Patent Rule 1.5 Patent Pilot Project, case shall be reassigned to a designated patent judge. (rg, )

Entry #5 • 2015-09-21
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc